Home / Resources / A Steady Flow Toward Approval: Key Potential Drug Launches in 2025

A Steady Flow Toward Approval: Key Potential Drug Launches in 2025

Infographic
商業化支援サービス
Citeline Commercial Infographic: A Steady Flow Toward Approval

Key Potential Drug Launches in 2025

According to Biomedtracker’s Key Potential Drug Launches in 2025 report, the pipeline is set to deliver 69 key launches across 66 discrete drugs next year.* This is roughly the same number as predicted for 2024 back in July 2023.

*Data as of July 2024

Related products
Analyst visualizing the drug development process on screen
Biomedtracker
医薬品開発パイプラインのリアルタイム追跡と分析
Analyst using Datamonitor Healthcare for a market assesment
Datamonitor Healthcare
推測なしでの製薬市場評価のための分析およびデータツール
Getting the full drug RandD landscape
Pharmaprojects
世界的な医薬品研究開発の状況を追跡し、分析するための業界標準

Related resources

A variety of pills and tablets arranged neatly on a wooden table surface
OCT 09, 2024
Report
商業化支援サービス

Key Potential Drug Launches in 2025

Biomedtracker’s Key Potential Drug Launches in 2025 report provides a longer-term look at some key late-stage drugs projected to hit the market in 2025.

Citeline professional presenting the Q4 2024 Outlook Report provided by Biomedtracker.
SEP 30, 2024
Report
商業化支援サービス

Q4 Outlook Report: Key Industry Drugs, Devices & Deals

In this report, we cover catalysts from 24 drugs, devices, diagnostics, and deals expected to occur in Q4 2024.

View all